Related Experiment Videos
Memory impairment means less pain for mice.
Gisèle Pickering1, Eric Chapuy, Alain Eschalier
1INSERM EMI 9904, Clinical Pharmacology Department, University Hospital, Clermont-Ferrand, France. gisele.pickering@u-clermont1.fr
Gerontology
|April 29, 2004
Summary
Memory impairment reduces pain sensitivity. This study found that mice with impaired memory, induced by scopolamine or ketamine, showed decreased pain responses, highlighting the link between cognitive function and nociception.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Clinical observations suggest a link between memory deterioration (e.g., Alzheimer's disease) and reduced pain sensitivity.
- Understanding this relationship is crucial for managing pain in individuals with cognitive impairments.
Purpose of the Study:
- To investigate the relationship between memory impairment and pain perception.
- To examine the behavior of memory-impaired mice in nociceptive tests.
Main Methods:
- Mice were administered scopolamine (cholinergic antagonist) or ketamine (N-methyl-D-aspartate receptor antagonist) to induce memory impairment.
- Nociceptive responses were assessed using a hotplate test over several days.
- Response times to thermal stimuli were recorded to measure pain sensitivity.
Main Results:
- Mice with induced memory impairment exhibited prolonged response times in hotplate tests, indicating reduced pain sensitivity.
- The effect was observed with both scopolamine and ketamine treatments.
- Response times normalized after drug administration ceased, suggesting a reversible effect.
Conclusions:
- Pain sensitivity is dependent on the integrity of central cholinergic and N-methyl-D-aspartate receptor systems.
- Memory-impaired mice demonstrate diminished pain sensitivity compared to control subjects.
- Further research into neurotransmitter interactions is needed to understand pain and analgesia in cognitive impairment and dementia.